Alkermes plc

NasdaqGS:ALKS Stock Report

Market Cap: US$4.8b

Alkermes Management

Management criteria checks 3/4

Alkermes' CEO is Richard Pops, appointed in Sep 2011, has a tenure of 13.25 years. total yearly compensation is $9.44M, comprised of 12.5% salary and 87.5% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $34.86M. The average tenure of the management team and the board of directors is 5.6 years and 4 years respectively.

Key information

Richard Pops

Chief executive officer

US$9.4m

Total compensation

CEO salary percentage12.5%
CEO tenure13.3yrs
CEO ownership0.7%
Management average tenure5.6yrs
Board average tenure4yrs

Recent management updates

Recent updates

We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt

Dec 17
We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt

Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth

Nov 24

Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement

Oct 14
Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement

Is Alkermes (NASDAQ:ALKS) A Risky Investment?

Sep 17
Is Alkermes (NASDAQ:ALKS) A Risky Investment?

Alkermes: Fairly Valued After Post-Earnings Bump

Jul 28

Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?

Jul 26
Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?

Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry

Jul 04
Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry

The Bottom Fishing Club: Alkermes Has Great Value And Safety

May 17

Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals

May 08
Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals

Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data

Apr 09

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Apr 08
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet

Jan 26

Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Nov 01
Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Nov 01
Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

Jul 15
Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Jun 07
There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Apr 10
Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Mar 20
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes upgraded to neutral at BofA on improved risk/reward outlook

Oct 14

Alkermes holder Sarissa Capital says it may look to increase its stake

Oct 07

Alkermes: Nothing Stands Out As Interesting

Sep 26

Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Aug 29
Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Alkermes initiated at neutral at Piper Sandler as company in transition

Aug 16

Alkermes Q2 2022 Earnings Preview

Jul 26

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Jun 27
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

May 16
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

CEO Compensation Analysis

How has Richard Pops's remuneration changed compared to Alkermes's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$387m

Jun 30 2024n/an/a

US$386m

Mar 31 2024n/an/a

US$570m

Dec 31 2023US$9mUS$1m

US$519m

Sep 30 2023n/an/a

US$455m

Jun 30 2023n/an/a

US$300m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022US$10mUS$1m

-US$33m

Sep 30 2022n/an/a

-US$129m

Jun 30 2022n/an/a

-US$94m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$9mUS$1m

US$76m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$95m

Dec 31 2020US$8mUS$1m

-US$111m

Sep 30 2020n/an/a

-US$74m

Jun 30 2020n/an/a

-US$126m

Mar 31 2020n/an/a

-US$139m

Dec 31 2019US$15mUS$1m

-US$197m

Sep 30 2019n/an/a

-US$201m

Jun 30 2019n/an/a

-US$183m

Mar 31 2019n/an/a

-US$173m

Dec 31 2018US$17mUS$1m

-US$139m

Sep 30 2018n/an/a

-US$139m

Jun 30 2018n/an/a

-US$141m

Mar 31 2018n/an/a

-US$152m

Dec 31 2017US$9mUS$964k

-US$158m

Compensation vs Market: Richard's total compensation ($USD9.44M) is above average for companies of similar size in the US market ($USD6.66M).

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.

CEO

Richard Pops (62 yo)

13.3yrs

Tenure

US$9,442,066

Compensation

Mr. Richard F. Pops has been the Chief Executive Officer and Director of Alkermes PLC since September 2011 and its Chairman since September 16, 2011. Mr. Pops was the Founder of Genomics Collaborative, Inc...

Leadership Team

NamePositionTenureCompensationOwnership
Richard Pops
Chairman & CEO13.3yrsUS$9.44m0.73%
$ 34.9m
Blair Jackson
Interim Principal Financial Officer3.9yrsUS$4.56m0.098%
$ 4.7m
David Gaffin
Executive VP8.6yrsUS$4.14m0.10%
$ 4.9m
Iain Brown
Senior VP & CFOless than a yearUS$3.21m0.072%
$ 3.4m
Craig Hopkinson
Executive VP of Research & Development and Chief Medical Officer7.6yrsUS$4.23m0.029%
$ 1.4m
Floyd Bloom
Founderno dataUS$324.96kno data
Samuel Parisi
Interim Principal Accounting Officer & VP of Financeless than a yearno data0.0048%
$ 228.1k
Thomas Harvey
Chief Information Officer & Senior VP of IT6.7yrsno datano data
Sandra Coombs
Senior Vice President of Corporate Affairs & Investor Relationsno datano datano data
Stephen Schiavo
Senior VP & Chief Human Resources Officer4.5yrsno datano data
Peter Norman
Senior Vice President of Policy & Government Relationsno datano datano data
Declan O'Connor
Senior Vice President of Operations and Environmentno datano datano data

5.6yrs

Average Tenure

55yo

Average Age

Experienced Management: ALKS's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Richard Pops
Chairman & CEO13.3yrsUS$9.44m0.73%
$ 34.9m
Brian McKeon
Independent Director4yrsUS$482.04k0.023%
$ 1.1m
Nancy Snyderman
Independent Director8.6yrsUS$482.04k0.016%
$ 751.1k
Nancy Lurker
Independent Directorless than a yearno datano data
Shane Cooke
Independent Director6.8yrsUS$449.04k0.062%
$ 3.0m
David Daglio
Independent Director4yrsUS$474.04k0.067%
$ 3.2m
Cato Laurencin
Independent Director3.1yrsUS$459.04k0.014%
$ 679.9k
Frank Wilson
Lead Independent Director5.3yrsUS$486.65k0.015%
$ 738.7k
Christopher Wright
Independent Director2.6yrsUS$463.12k0.0089%
$ 426.0k
Richard Brian Gaynor
Independent Director5.3yrsUS$464.69k0.015%
$ 738.7k
Emily Alva
Independent Director3.6yrsUS$469.04k0.017%
$ 806.6k

4.0yrs

Average Tenure

62yo

Average Age

Experienced Board: ALKS's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 22:50
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alkermes plc is covered by 36 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Robert HazlettBMO Capital Markets U.S. (Historical)
Jason Matthew GerberryBofA Global Research